Endosane Brings New Hope For Patients With Mental Health Conditions
Executive Summary
Endosane is a new take on developing drugs. Endosane is a joint venture of a group of researchers (Prof. Leweke and Dr. Rohleder) and the Sanity Group. Their goal is to apply cannabinoid compounds to develop drugs for neurologic and psychiatric applications.
Our background is in neurology and psychiatry … we think this area has not received as much attention in drug development as it deserves.
Max Narr, MD ENDOSANE
Subscribe Here
We are always sharing new resources with you. Find all of our options below. We want to make sure that we provide what’s best for your growing team, so please take a look at these additional ways in which can help!
Our Sponsor Startupraven
A startup’s journey can be a tough one, but it doesn’t have ́to feel like you’re alone on your quest! Invest in others’ success with us by joining our community of entrepreneurs who are building amazing things every day — no matter how big or small their ideas may seem at first glance.
The best way to find investors and cooperation partners for early-stage startups. Sign up here:
The Video Interview is set to go live on Jun 9, 2022
The Audio Interview
You can subscribe to our podcasts here.
The Guest
In this interview, our guest ist Max Narr (https://www.linkedin.com/in/max-narr-6a3b2a18a), MD at Berlin-based health care startup Endosane (https://endosane.com/). He is also Chief Investment Officer of Sanity Group (https://sanitygroup.com/), which develops products out of the components of cannabis.
The Startup
Endosane (https://endosane.com/) is a joint venture of Sanity Group (https://sanitygroup.com/) and a group of researchers. Max says it is Sanity’s take on developing drugs, partly based on cannabis derivatives. Their drug development is advancing the research of Prof. Leweke and Dr. Rohleder on cannabinoids for medical use.
Sanity Group
Endosane has close ties (capital and personal wise) with Sanity Group. You can learn more about Finn Hänsel, the founder of Sanity Group, and his plans for the future in our interview with him here:
Venture Capital Funding
Endosane is open to talking to external investors with contacts in relevant fields. Reach out directly to Max.
Tune in to our Internet Radio Station here:
Further Readings / Additional Resources
- Liquor cerebrospinalis / Cerebrospinal fluid https://en.wikipedia.org/wiki/Cerebrospinal_fluid
- Cannabinoids https://en.wikipedia.org/wiki/Cannabinoid
- Phases of clinical trials https://en.wikipedia.org/wiki/Phases_of_clinical_research
Feedback
We are always looking for ways to make the show better. Please take this opportunity and share your feedback with us! You can also suggest topics or interview partners that you’d like featured on future episodes by leaving a comment below — we would love to hear from YOU!!!
The Interviewer
This interview was conducted by Jörn “Joe” Menninger, startup scout, founder, and host of Startuprad.io. Reach out to him:
Keep Up to Date
Here is our publication calendar:
